Orthobiologics Market Size, Share and Industry Analysis by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), By Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Orthobiologics Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Orthobiologics market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Orthobiologics market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Orthobiologics Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Orthobiologics Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Orthobiologics Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
p2
Orthobiologics Market Players

  
 Zimmer Biomet
  
Genzyme Corporation (Sanofi)
  
DePuy Synthes (Johnson & Johnson Services, Inc.)
  
Stryker
  
Medtronic
  
Wright Medical Group N.V.
  
Anika Therapeutics, Inc.
  
SeaSpine
  
Bioventus
  
RTI Surgical Holdings, Inc.
  
Musculoskeletal Transplant Foundation
  
Other players

Report Coverage

The rising number of reconstructive and regenerative surgeries have resulted in increased demand for orthobiologic products. Orthobiologics are the products that are used during surgeries to aid quick healing of orthopedic injuries. These are made from products ranging from growth stimulators to synthetic bone substitutes.

Along with this, the orthobiologics market analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of soft tissue injuries for key countries, number of spinal fusion surgery for key countries, regulatory scenario in key countries, new product launch, key mergers and acquisitions: recent industry developments, and others.

Segmentation

By Product Type

  
Viscosupplements
  
Bone Growth Stimulators
  
Bone Morphogenetic Proteins (BMP)
  
Platelet-Derived Growth Factors
  
Demineralized Bone Matrix (DBM)
  
Synthetic Bone Substitutes
  
Stem Cells
  
Allografts
  
Others

By Application

  
Spinal Fusion
  
Maxillofacial & Dental
  
Soft Tissue Repair
  
Reconstructive & Fracture Surgery
  
Others

By End User

  
Hospitals
  
Ambulatory Surgical Centers
  
Speciality Clinics

By Geography

  
North America (USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Developments

In March 2019, Bioventus launched OSTEOAMP SELECT Fibers an allograft for spine, foot & ankle, orthopedic and trauma patients, giving surgeons more options for bone healing and remodeling while delivering positive patient outcomes.

In March 2019, SEIKAGAKU CORPORATION launched HYLINK a single-injection viscosupplement for the treatment of patients with knee osteoarthritis.

In January 2019, Bioventus launched DUROLANE a single-injection joint-fluid for treatment of patients with osteoarthritis.